Keep an eye on Tilray (TLRY).
CEO Irwin Simon just bought 53,700 shares on Jan. 12.
Plus, as noted by Marijuana Moment, “The stage is set for another ‘productive year’ in federal marijuana reform—with lawmakers positioned to leverage “tremendous bipartisan investments” from 2023, while pushing the Biden administration to move further on the issue ahead of this year’s election.”
Helping, “The U.S. government has released hundreds of pages of documents related to its ongoing review of marijuana’s status under federal law, officially confirming for the first time that health officials have recommended the Drug Enforcement Administration (DEA) place cannabis in Schedule III of the Controlled Substances Act (CSA).”